Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity
Completed
Conditions studied: Obesity, Growth Hormone
In brief
Obesity is one of the leading causes of cardiovascular-related diseases, including diabetes and heart disease. Obesity, and more specifically abdominal obesity, may cause decreased growth hormone (GH) levels. It is believed that GH deficiency may contribute to increased cardiovascular risk by affecting insulin resistance, inflammatory markers, and blood cholesterol levels. This study will determine the occurrence of GH deficiency in abdominal obesity and whether GH deficiency is associated with increased cardiovascular risk beyond traditional risk factors.
Key facts
- Study ID
- NCT00562796
- Run by
- Massachusetts General Hospital
- People needed
- 149
- Starts
- 2007-11-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2011-08-23
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.